[HIV and dyslipidemia - reasons and therapy]

MMW Fortschr Med. 2020 Jun;162(Suppl 2):54-61. doi: 10.1007/s15006-020-0015-9.
[Article in German]
No abstract available

Keywords: HIV infection; inflammation; lipid abnormalities; lipid lowering therapy; risk for cardiovascular disease.

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Cardiovascular Diseases*
  • Dyslipidemias* / complications
  • HIV Infections* / complications
  • Humans
  • Hypolipidemic Agents

Substances

  • Hypolipidemic Agents